MADRID–(BUSINESS WIRE)– #AdvancedMelanoma–Chipscreen Biosciences continues to explore its IO 2.0 strategy based on HDACi + IO.
MADRID–(BUSINESS WIRE)– #AdvancedMelanoma–Chipscreen Biosciences continues to explore its IO 2.0 strategy based on HDACi + IO.